Inventor · disambiguated record
Charles Allerson
Also filed as: ALLERSON CHARLES · ALLERSON CHARLES R
23 granted patents·43 pending applications·2,222 citations·filing 2002–2025
97Inventor score
Files withBHAT BALKRISHEN17ISIS PHARMACEUTICALS INC13REGULUS THERAPEUTICS INC13ALLERSON CHARLES6IONIS PHARMACEUTICALS INC4
Top patents by PatentIndex Score
66 records- 0199US9005906B2Tetrahydropyran nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2014·Granted Apr 14, 2015·163 cites·24 claims
- 0299US8440803B2Tetrahydropyran nucleic acid analogsSWAYZE ERIC E·Filed 2011·Granted May 14, 2013·158 cites·16 claims
- 0399US7696345B2Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2003·Granted Apr 13, 2010·426 cites·24 claims
- 0498US8796437B2Tetrahydropyran nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2013·Granted Aug 5, 2014·85 cites·23 claims
- 0598US8124745B2Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulationALLERSON CHARLES·Filed 2010·Granted Feb 28, 2012·203 cites·20 claims
- 0698US8088904B2Tetrahydropyran nucleic acid analogsSWAYZE ERIC E·Filed 2008·Granted Jan 3, 2012·164 cites·30 claims
- 0798US7939677B2Oligomeric compounds comprising 4′-thionucleosides for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2010·Granted May 10, 2011·152 cites·20 claims
- 0898US7875733B2Oligomeric compounds comprising 4′-thionucleosides for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2004·Granted Jan 25, 2011·159 cites·6 claims
- 0998US7569686B1Compounds and methods for synthesis of bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2007·Granted Aug 4, 2009·501 cites·26 claims
- 1096US10266825B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationIONIS PHARMACEUTICALS INC·Filed 2017·Granted Apr 23, 2019·10 cites·21 claims
- 1194US6610492B1Base-modified nucleotides and cleavage of polynucleotides incorporating themVARIAGENICS INC·Filed 2002·Granted Aug 26, 2003·108 cites·15 claims
- 1292US9708610B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationIONIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 18, 2017·6 cites·19 claims
- 1390US8604183B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationALLERSON CHARLES·Filed 2003·Granted Dec 10, 2013·20 cites·24 claims
- 1488US9193752B25′-substituted bicyclic nucleosides and oligomeric compounds prepared therefromMIGAWA MICHAEL T·Filed 2011·Granted Nov 24, 2015·14 cites·25 claims
- 1588US8779118B2Base modified bicyclic nucleosides and oligomeric compounds prepared therefromALLERSON CHARLES·Filed 2011·Granted Jul 15, 2014·14 cites·42 claims
- 1686US9150606B2Compositions comprising alternating 2'-modified nucleosides for use in gene modulationALLERSON CHARLES·Filed 2005·Granted Oct 6, 2015·9 cites·21 claims
- 1785US8394947B2Positionally modified siRNA constructsBHAT BALKRISHEN·Filed 2004·Granted Mar 12, 2013·17 cites·15 claims
- 1883US2024141350A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1982US9150605B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationALLERSON CHARLES·Filed 2004·Granted Oct 6, 2015·9 cites·22 claims
- 2078US2023109466A1Compositions for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2177US2022162603A1Compositions comprising alternating 2'-modified nucleosides for use in gene modulationIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2275US2022213483A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2374US11078485B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationIONIS PHARMACEUTICALS INC·Filed 2019·Granted Aug 3, 2021·0 cites·7 claims
- 2474US6994998B1Base-modified nucleotides and their use for polymorphism detectionSEQUENOM INC·Filed 2002·Granted Feb 7, 2006·3 cites·20 claims
- 2571US2025283082A1Compositions for Treatment of Polycystic Kidney DiseaseREGULUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2670US2021095282A1Modified Oligonucleotides for Treatment of Polycystic Kidney DiseaseREGULUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2769US2020392501A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2867US2007173474A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 2967US2007179109A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3067US2007179106A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3167US2007123484A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3267US2007167390A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3367US2007167392A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3467US2007185046A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3567US2022380767A1Methods and compositions for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3667US2007167391A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3767US2007185047A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3867US2007179108A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3966US2007179107A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 4064US12497616B2Compounds targeting PMP22 for the treatment of Charcot-Marie-Tooth diseaseNOVARTIS AG·Filed 2024·Granted Dec 16, 2025·0 cites·28 claims
- 4164US12005120B2Galnac conjugated modified oligonucleotides as miR-122 inhibitor having HCV antiviral activity with reduced hyperbilirubinemia side-effectREGULUS THERAPEUTICS INC·Filed 2019·Granted Jun 11, 2024·0 cites·22 claims
- 4264US6855500B2Fluorescence-based genotypingSEQUENOM INC·Filed 2002·Granted Feb 15, 2005·1 cites·26 claims
- 4364US2020165606A1Modified Oligonucleotides for Treatment of Polycystic Kidney DiseaseREGULUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4464US2007172948A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 4564US2007173475A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 4664US2007166734A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 4763US2025333745A1Methods and compositions for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4863US2016017328A1Double strand compositions comprising differentially modified strands for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4963US2019345494A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 5062US2011046206A1Double strand compositions comprising differentially modified strands for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →